hVIVO

H1 trading statement

  • Jul 22 2025, 07:10 IST/BST
  • Colin Grant
  • Company Report
  • 6 page(s)
  • Sectors : Pharma and healthcare
  • Companies : hVIVO

Ratings and price correct at time of issue.

  • hVIVO

    Closing Price: 10.0p

  • RATING 11/10/23

  • PREVIOUS RATING 17/02/20

    UNDER REVIEW

Person's Name

Colin Grant

Analyst

DAVY VIEW

hVIVO has issued a trading statement for H1, reiterating FY2025 revenue guidance and indicating a slight improvement in the outlook for EBITDA. The sector remains challenged due to ongoing weakness in biotech funding, but the strategy to diversify the company’s revenue streams is supportive.

View full article

Download full report with analyst certification and important disclosures

Jul 22 2025, 07:10 IST/BST

Download